Table 1
PATIENT CHARACTERISTICS | N = 46 |
|---|---|
Median age (range) | 55 (33–76) |
Median performance status (range) | 2 (0–4) |
Median number of prior chemotherapies (range) | 2 (1–5) |
Summary of prior chemotherapy | Â |
Number of treatments prior to ATP-TCA | No. Patients |
1 | 13 (28%) |
2 | 18 (39%) |
3 | 10 (22%) |
4 | 4 (9%) |
5 | 1 (2%) |
FIGO stage (No.) | Â |
IIIc | 40 (87%) |
IV | 6 (13%) |
Patients with non-serous histology | 6 (13%) |
Platinum-refractory patients* | 18 (39%) |
Patients with a Cisplatin Index >350 on first ATP-TCA | 33 (72%) |
Patients with ascites | 37 (80%) |